| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Chief Scientific Officer & EVP
1 company
David N Cook last filed a Form 4 in January 2019, as See Remarks at MCRB. David N Cook's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 147,435 shares of MCRB. The MCRB filings lean toward selling, a net 94,738 shares.
David N Cook has 9 Form 4 filings on record from June 2015 to January 2019, all as Seres Therapeutics (MCRB), 2015–2019.
The 15 reported transactions were 7 open-market sales, 5 option or other derivative awards, 2 option exercises and 1 conversion.
Counted by filing, the open-market trades come to no purchases and 5 sales worth about $2.6M.
The largest open-market sale was 61,000 shares of MCRB at an average $26.16 on April 4, 2016, about $1.6M.
Shares as reported in the last Form 4 for each company; the most recent is from January 2019. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2018 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE | 1,738 | $11.02 | $19,152.76 | -1.2% | |
| Jun 2, 2016 | MCRB Seres Therapeutics, Inc. | Chief Scientific Officer & EVP | Sell | 8,000 | $31.00 | $248,000.00 | -5.5% | |
| Jun 1, 2016 | MCRB Seres Therapeutics, Inc. | Chief Scientific Officer & EVP | Sell | 16,000 | $29.43 | $470,880.00 | -10.0% | |
| Apr 7, 2016 | MCRB Seres Therapeutics, Inc. | Chief Scientific Officer & EVP | Sell | 8,000 | $31.00 | $248,000.00 | -4.7% | |
| Apr 4, 2016 | MCRB Seres Therapeutics, Inc. | Chief Scientific Officer & EVP | Sell | 61,000 | $26.16 | $1,595,586.00 | -26.6% |